1262 Immune checkpoint inhibitor-induced inflammatory arthritis is associated with cutaneous, endocrine, and gastrointestinal immune-related adverse events: a machine learning approach
Steven Tran(Northwestern University), Theresa L. Walunas(Northwestern University), Jonathan Theros(Northwestern University), Sara Malik(Northwestern University), Kian J. Rahbari(Vanderbilt University Medical Center), Jordan John(Northwestern University), Nisha Mohindra(Fox Chase Cancer Center), Luke V. Rasmussen(Northwestern University), Jeffrey A. Sosman(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Abel Kho(Northwestern University), Kyle Tegtmeyer(Northwestern University), Kelly Vogel(Northwestern University), Carlos Galvez(Northwestern University), Patrick V Dinh(Northwestern University), Yuan Luo(Chongqing Three Gorges Central Hospital), Jennifer A. Pacheco(University of Arizona), Jean Z. Lin(Northwestern University), Charles Miller(Northwestern University)
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
|Journal of Clinical Oncology|2014|2.2k